Table 2. Timeline of the T-FORMOSA study.

Time	Task
November to December 2021	First IRB approval and site correspondence training
January 3 2022	First site first patient in
45200	Last patient in
45413	Interim report of the baseline characteristics
October to December 2024	Data locked
45778	Reporting the main results
Every 3-5 years up to 2045	Following up long-term outcomes using NHIRD

IRB, Institutional Review Board; NHIRD, national health insurance research database; T-FORMOSA, TSOC-Fully Organized Registry for the Management Of Symptomatic ACS Study.